133 related articles for article (PubMed ID: 15554095)
1. Treatment patterns for stage III colon cancer and factors related to receipt of postoperative chemotherapy in Louisiana.
Wu X; Chen VW; Andrews PA; Chen L; Hsieh M; Fontham ET
J La State Med Soc; 2004; 156(5):255-61. PubMed ID: 15554095
[TBL] [Abstract][Full Text] [Related]
2. Initial treatment patterns for clinically localized prostate cancer and factors associated with the treatment in Louisiana.
Wu X; Chen VW; Andrews PA; Chen L; Ahmed MN; Schmidit B; Hsieh M; Fontham ET
J La State Med Soc; 2005; 157(4):188-94. PubMed ID: 16250368
[TBL] [Abstract][Full Text] [Related]
3. Impact of patient age and comorbidity on surgeon versus oncologist preferences for adjuvant chemotherapy for stage III colon cancer.
Krzyzanowska MK; Regan MM; Powell M; Earle CC; Weeks JC
J Am Coll Surg; 2009 Feb; 208(2):202-9. PubMed ID: 19228531
[TBL] [Abstract][Full Text] [Related]
4. Adjuvant chemotherapy for stage II colon cancer: influence of care structures' characteristics on a controversial clinical practice.
Alter E; Phelip JM; Guilhot JN; Matysiak M; Vermorel M; Roblin X
Eur J Gastroenterol Hepatol; 2007 Nov; 19(11):995-1001. PubMed ID: 18049170
[TBL] [Abstract][Full Text] [Related]
5. Patterns of care for adjuvant therapy in a random population-based sample of patients diagnosed with colorectal cancer.
Cronin DP; Harlan LC; Potosky AL; Clegg LX; Stevens JL; Mooney MM
Am J Gastroenterol; 2006 Oct; 101(10):2308-18. PubMed ID: 17032196
[TBL] [Abstract][Full Text] [Related]
6. Surgeon characteristics and receipt of adjuvant radiotherapy in women with breast cancer.
Hershman DL; Buono D; McBride RB; Tsai WY; Joseph KA; Grann VR; Jacobson JS
J Natl Cancer Inst; 2008 Feb; 100(3):199-206. PubMed ID: 18230795
[TBL] [Abstract][Full Text] [Related]
7. Comparison of treatment received versus long-standing guidelines for stage III colon and stage II/III rectal cancer patients diagnosed in Alberta, Saskatchewan, and Manitoba in 2004.
Cree M; Tonita J; Turner D; Nugent Z; Alvi R; Barss R; King C; Winget M
Clin Colorectal Cancer; 2009 Jul; 8(3):141-5. PubMed ID: 19632928
[TBL] [Abstract][Full Text] [Related]
8. A patient's race/ethnicity does not explain the underuse of appropriate adjuvant therapy in colorectal cancer.
McGory ML; Zingmond DS; Sekeris E; Bastani R; Ko CY
Dis Colon Rectum; 2006 Mar; 49(3):319-29. PubMed ID: 16475031
[TBL] [Abstract][Full Text] [Related]
9. Retrospective study of the effect of comorbidity on use of adjuvant chemotherapy in older women with breast cancer in a tertiary care setting.
Hawfield A; Lovato J; Covington D; Kimmick G
Crit Rev Oncol Hematol; 2006 Sep; 59(3):250-5. PubMed ID: 16527489
[TBL] [Abstract][Full Text] [Related]
10. Adjuvant chemotherapy for colon carcinoma with positive lymph nodes: use and benefit in routine health care practice.
Bouchardy C; Queneau PE; Fioretta G; Usel M; Zellweger M; Neyroud I; Raymond L; de Wolf C; Sappino AP
Br J Cancer; 2001 Nov; 85(9):1251-7. PubMed ID: 11720457
[TBL] [Abstract][Full Text] [Related]
11. Population variations in the initial treatment of non-small-cell lung cancer.
Potosky AL; Saxman S; Wallace RB; Lynch CF
J Clin Oncol; 2004 Aug; 22(16):3261-8. PubMed ID: 15310770
[TBL] [Abstract][Full Text] [Related]
12. Patient age and comorbidity are major determinants of adjuvant chemotherapy use for stage III colon cancer in routine clinical practice.
Ananda S; Field KM; Kosmider S; Compston D; Desai J; Lim LC; Barnett FS; Jones IT; Skinner I; Gibbs P
J Clin Oncol; 2008 Sep; 26(27):4516-7; author reply 4517-8. PubMed ID: 18802167
[No Abstract] [Full Text] [Related]
13. Influence of race, insurance, socioeconomic status, and hospital type on receipt of guideline-concordant adjuvant systemic therapy for locoregional breast cancers.
Wu XC; Lund MJ; Kimmick GG; Richardson LC; Sabatino SA; Chen VW; Fleming ST; Morris CR; Huang B; Trentham-Dietz A; Lipscomb J
J Clin Oncol; 2012 Jan; 30(2):142-50. PubMed ID: 22147735
[TBL] [Abstract][Full Text] [Related]
14. Chemotherapy use, outcomes, and costs for older persons with advanced non-small-cell lung cancer: evidence from surveillance, epidemiology and end results-Medicare.
Ramsey SD; Howlader N; Etzioni RD; Donato B
J Clin Oncol; 2004 Dec; 22(24):4971-8. PubMed ID: 15611512
[TBL] [Abstract][Full Text] [Related]
15. Adjuvant chemotherapy for stage III colon cancer: do physicians agree about the importance of patient age and comorbidity?
Keating NL; Landrum MB; Klabunde CN; Fletcher RH; Rogers SO; Doucette WR; Tisnado D; Clauser S; Kahn KL
J Clin Oncol; 2008 May; 26(15):2532-7. PubMed ID: 18487570
[TBL] [Abstract][Full Text] [Related]
16. Insurance status and the use of guideline therapy in the treatment of selected cancers.
Harlan LC; Greene AL; Clegg LX; Mooney M; Stevens JL; Brown ML
J Clin Oncol; 2005 Dec; 23(36):9079-88. PubMed ID: 16301598
[TBL] [Abstract][Full Text] [Related]
17. Effect of age on survival benefit of adjuvant chemotherapy in elderly patients with Stage III colon cancer.
Zuckerman IH; Rapp T; Onukwugha E; Davidoff A; Choti MA; Gardner J; Seal B; Mullins CD
J Am Geriatr Soc; 2009 Aug; 57(8):1403-10. PubMed ID: 19563521
[TBL] [Abstract][Full Text] [Related]
18. Timing of adjuvant chemotherapy initiation after surgery for stage III colon cancer.
Hershman D; Hall MJ; Wang X; Jacobson JS; McBride R; Grann VR; Neugut AI
Cancer; 2006 Dec; 107(11):2581-8. PubMed ID: 17078055
[TBL] [Abstract][Full Text] [Related]
19. Disparities and trends in sentinel lymph node biopsy among early-stage breast cancer patients (1998-2005).
Chen AY; Halpern MT; Schrag NM; Stewart A; Leitch M; Ward E
J Natl Cancer Inst; 2008 Apr; 100(7):462-74. PubMed ID: 18364506
[TBL] [Abstract][Full Text] [Related]
20. Survival and time interval from surgery to start of chemotherapy among colon cancer patients.
Zeig-Owens R; Gershman ST; Knowlton R; Jacobson JS
J Registry Manag; 2009; 36(2):30-41; quiz 61-2. PubMed ID: 19694115
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
